28
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      GABA B receptor phosphorylation regulates KCTD12-induced K + current desensitization

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          GABA B receptors assemble from GABA B1 and GABA B2 subunits. GABA B2 additionally associates with auxiliary KCTD subunits (named after their K + channel tetramerization-domain). GABA B receptors couple to heterotrimeric G–proteins and activate inwardly-rectifying K + channels through the βγ subunits released from the G-protein. Receptor-activated K + currents desensitize in the sustained presence of agonist to avoid excessive effects on neuronal activity. Desensitization of K + currents integrates distinct mechanistic underpinnings. GABA B receptor activity reduces protein kinase-A activity, which reduces phosphorylation of serine-892 in GABA B2 and promotes receptor degradation. This form of desensitization operates on the time scale of several minutes to hours. A faster form of desensitization is induced by the auxiliary subunit KCTD12, which interferes with channel activation by binding to the G-protein βγ subunits. Here we show that the two mechanisms of desensitization influence each other. Serine-892 phosphorylation in heterologous cells rearranges KCTD12 at the receptor and slows KCTD12-induced desensitization. Likewise, protein kinase-A activation in hippocampal neurons slows fast desensitization of GABA B receptor-activated K + currents while protein kinase-A inhibition accelerates fast desensitization. Protein kinase-A fails to regulate fast desensitization in KCTD12 knock-out mice or knock-in mice with a serine-892 to alanine mutation, thus demonstrating that serine-892 phosphorylation regulates KCTD12-induced desensitization in vivo. Fast current desensitization is accelerated in hippocampal neurons carrying the serine-892 to alanine mutation, showing that tonic serine-892 phosphorylation normally limits KCTD12-induced desensitization. Tonic serine-892 phosphorylation is in turn promoted by assembly of receptors with KCTD12. This cross-regulation of serine-892 phosphorylation and KCTD12 activity sharpens the response during repeated receptor activation.

          Related collections

          Most cited references32

          • Record: found
          • Abstract: not found
          • Article: not found

          A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells.

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Molecular structure and physiological functions of GABA(B) receptors.

            GABA(B) receptors are broadly expressed in the nervous system and have been implicated in a wide variety of neurological and psychiatric disorders. The cloning of the first GABA(B) receptor cDNAs in 1997 revived interest in these receptors and their potential as therapeutic targets. With the availability of molecular tools, rapid progress was made in our understanding of the GABA(B) system. This led to the surprising discovery that GABA(B) receptors need to assemble from distinct subunits to function and provided exciting new insights into the structure of G protein-coupled receptors (GPCRs) in general. As a consequence of this discovery, it is now widely accepted that GPCRs can exist as heterodimers. The cloning of GABA(B) receptors allowed some important questions in the field to be answered. It is now clear that molecular studies do not support the existence of pharmacologically distinct GABA(B) receptors, as predicted by work on native receptors. Advances were also made in clarifying the relationship between GABA(B) receptors and the receptors for gamma-hydroxybutyrate, an emerging drug of abuse. There are now the first indications linking GABA(B) receptor polymorphisms to epilepsy. Significantly, the cloning of GABA(B) receptors enabled identification of the first allosteric GABA(B) receptor compounds, which is expected to broaden the spectrum of therapeutic applications. Here we review current concepts on the molecular composition and function of GABA(B) receptors and discuss ongoing drug-discovery efforts.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Emerging roles for G protein-gated inwardly rectifying potassium (GIRK) channels in health and disease.

              G protein-gated inwardly rectifying potassium (GIRK) channels hyperpolarize neurons in response to activation of many different G protein-coupled receptors and thus control the excitability of neurons through GIRK-mediated self-inhibition, slow synaptic potentials and volume transmission. GIRK channel function and trafficking are highly dependent on the channel subunit composition. Pharmacological investigations of GIRK channels and studies in animal models suggest that GIRK activity has an important role in physiological responses, including pain perception and memory modulation. Moreover, abnormal GIRK function has been implicated in altering neuronal excitability and cell death, which may be important in the pathophysiology of diseases such as epilepsy, Down's syndrome, Parkinson's disease and drug addiction. GIRK channels may therefore prove to be a valuable new therapeutic target.
                Bookmark

                Author and article information

                Journal
                0101032
                1015
                Biochem Pharmacol
                Biochem. Pharmacol.
                Biochemical pharmacology
                0006-2952
                1873-2968
                14 April 2015
                24 July 2014
                1 October 2014
                19 April 2015
                : 91
                : 3
                : 369-379
                Affiliations
                [a ]Department of Biomedicine, University of Basel, 4056 Basel, Switzerland
                [b ]Institute of Experimental Medicine, ASCR, Videnska 1083, 14220 Prague 4-Krc, Czech Republic
                [c ]Department of Neuroscience, Tufts University School of Medicine, Boston, MA 02111, United States
                Author notes
                [* ]Corresponding author at: Department of Biomedicine, Pharmazentrum, University of Basel, Klingelbergstrasse 50–70, CH-4056 Basel, Switzerland. Tel.: +41 61 267 1632; fax: +41 61 267 1628. bernhard.bettler@ 123456unibas.ch (B. Bettler)
                [1]

                Present address: Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

                [2]

                These authors contributed equally to this work.

                Article
                NIHMS678086
                10.1016/j.bcp.2014.07.013
                4402209
                25065880
                67623143-fc37-483e-8558-dd64bde44e2a
                © 2014 The Authors. Published by Elsevier Inc.

                This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/).

                History
                Categories
                Article

                Pharmacology & Pharmaceutical medicine
                gaba-b,g-protein coupled receptor,gpcr,pka,kir3
                Pharmacology & Pharmaceutical medicine
                gaba-b, g-protein coupled receptor, gpcr, pka, kir3

                Comments

                Comment on this article